[1]
2022. The concentration and type of monoclonal protein and their impact on clinical severity in patients with symptomatic myeloma . AMJ (Advanced Medical Journal) . 6, 2 (Jun. 2022), 160–171. DOI:https://doi.org/10.56056/amj.2022.147.